| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,537 |
3,817 |
$315K |
| 83655 |
|
8,706 |
6,853 |
$76K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
516 |
446 |
$27K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
376 |
253 |
$14K |
| 86480 |
|
42 |
39 |
$2K |
| 86703 |
|
160 |
139 |
$2K |
| 86803 |
|
127 |
107 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
59 |
58 |
$649.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
59 |
58 |
$649.00 |
| 86592 |
|
136 |
109 |
$439.92 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
26 |
19 |
$382.14 |
| 86706 |
|
40 |
26 |
$276.38 |
| 87340 |
|
27 |
27 |
$276.21 |